Home › Funds › Balyasny Asset Management › TECH
Balyasny Asset Management position in TECH
BIO-TECHNE CORP · Health Care
Balyasny Asset Management reported holding 3,403,731 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$246.7M, representing 0.90% of its reported portfolio and ranking #11 among its reported holdings. Balyasny Asset Management has disclosed TECH holdings in 8 of the last 18 reported quarters, going back to Q2 2022.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Balyasny Asset Management's TECH position evolved
Balyasny Asset Management first disclosed a stake in TECH in Q2 2022 at 78,390 shares (US$27.2M). The position peaked in Q3 2026 at 3,403,731 shares, worth US$246.7M. Across 8 filings, Balyasny Asset Management increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,403,731 shares valued at US$246.7M — an increase of 2,566,861 shares quarter over quarter.. Notable position changes include a 13502% increase in Q1 2023 (shares rose 10% over the following quarter), a 307% increase in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 78.39K | $27.17M | New |
| Q4 2022 | 3.93K | $326.05K | New |
| Q1 2023 | 535.11K | $39.70M | Add |
| Q2 2023 | 421.72K | $34.43M | Reduce |
| Q4 2024 | 47.07K | $3.39M | New |
| Q3 2025 | 805.83K | $44.83M | New |
| Q2 2026 | 836.87K | $59.12M | New |
| Q3 2026 | 3.40M | $246.67M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 25 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$560.3M), Ruane Cunniff & Goldfarb (Sequoia) (US$242.3M), WHITEBOX ADVISORS LLC (US$190.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 7.73M sh · $560.35M · Q3 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.34M sh · $242.26M · Q3 2026
- WHITEBOX ADVISORS LLC 2.62M sh · $190.15M · Q3 2026
- Qube Research & Technologies Ltd 2.38M sh · $172.44M · Q3 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on Balyasny Asset Management
FAQ
How long has Balyasny Asset Management held TECH?
Balyasny Asset Management has disclosed TECH holdings in 8 of the last 18 reported quarters, going back to Q2 2022.
What is Balyasny Asset Management's current position in TECH?
As of Q3 2026, Balyasny Asset Management holds 3.40M shares of TECH (BIO-TECHNE CORP), valued at $246.67M, representing 0.90% of its reported portfolio and ranking #11.
Has Balyasny Asset Management been buying or selling TECH?
In the latest 13F filing (Q3 2026), Balyasny Asset Management increased its position in TECH. The position peaked in Q3 2026 at 3.40M shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), WHITEBOX ADVISORS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.